Original Research

A combination of sorafenib and nilotinib reduces the growth of castrate-resistant prostate cancer

Archibald M, Pritchard T, Nehoff H, Rosengren RJ, Greish K, Taurin S

International Journal of Nanomedicine 2016, 11:179-201

Published Date: 8 January 2016